Global Iopromide Injection Market Growth 2026-2032

August 2026 | 79 pages | ID: G75080424376EN
LP Information

Abstracts

The global Iopromide Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Iopromide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Iopromide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Iopromide Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Iopromide Injection players cover Bayer HealthCare, Brilliant Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Iopromide Injection Industry Forecast? looks at past sales and reviews total world Iopromide Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Iopromide Injection sales for 2026 through 2032. With Iopromide Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iopromide Injection industry.

This Insight Report provides a comprehensive analysis of the global Iopromide Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iopromide Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Iopromide Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iopromide Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iopromide Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Iopromide Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 150 mg I/mL
• 240 mg I/mL
• 300 mg I/mL
• 370 mg I/mL

Segmentation by Application:

• CT
• Digital Subtraction Angiography
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bayer HealthCare
• Brilliant Pharmaceutical

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Iopromide Injection market?
• What factors are driving Iopromide Injection market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Iopromide Injection market opportunities vary by end market size?
• How does Iopromide Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Iopromide Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Iopromide Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Iopromide Injection by Country/Region, 2021, 2025 & 2032
2.2 Iopromide Injection Segment by Type
  2.2.1 150 mg I/mL
  2.2.2 240 mg I/mL
  2.2.3 300 mg I/mL
  2.2.4 370 mg I/mL
  2.2.5 Iopromide Injection Sales by Type
    2.2.5.1 Global Iopromide Injection Sales Market Share by Type (2021-2026)
    2.2.5.2 Global Iopromide Injection Revenue and Market Share by Type (2021-2026)
    2.2.5.3 Global Iopromide Injection Sale Price by Type (2021-2026)
2.3 Iopromide Injection Segment by Application
  2.3.1 CT
  2.3.2 Digital Subtraction Angiography
  2.3.3 Other
  2.3.4 Iopromide Injection Sales by Application
    2.3.4.1 Global Iopromide Injection Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Iopromide Injection Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Iopromide Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Iopromide Injection Breakdown Data by Company
  3.1.1 Global Iopromide Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Iopromide Injection Sales Market Share by Company (2021-2026)
3.2 Global Iopromide Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Iopromide Injection Revenue by Company (2021-2026)
  3.2.2 Global Iopromide Injection Revenue Market Share by Company (2021-2026)
3.3 Global Iopromide Injection Sale Price by Company
3.4 Key Manufacturers Iopromide Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Iopromide Injection Product Location Distribution
  3.4.2 Players Iopromide Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR IOPROMIDE INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Iopromide Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Iopromide Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Iopromide Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Iopromide Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Iopromide Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Iopromide Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Iopromide Injection Sales Growth
4.4 APAC Iopromide Injection Sales Growth
4.5 Europe Iopromide Injection Sales Growth
4.6 Middle East & Africa Iopromide Injection Sales Growth

5 AMERICAS

5.1 Americas Iopromide Injection Sales by Country
  5.1.1 Americas Iopromide Injection Sales by Country (2021-2026)
  5.1.2 Americas Iopromide Injection Revenue by Country (2021-2026)
5.2 Americas Iopromide Injection Sales by Type (2021-2026)
5.3 Americas Iopromide Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Iopromide Injection Sales by Region
  6.1.1 APAC Iopromide Injection Sales by Region (2021-2026)
  6.1.2 APAC Iopromide Injection Revenue by Region (2021-2026)
6.2 APAC Iopromide Injection Sales by Type (2021-2026)
6.3 APAC Iopromide Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Iopromide Injection by Country
  7.1.1 Europe Iopromide Injection Sales by Country (2021-2026)
  7.1.2 Europe Iopromide Injection Revenue by Country (2021-2026)
7.2 Europe Iopromide Injection Sales by Type (2021-2026)
7.3 Europe Iopromide Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Iopromide Injection by Country
  8.1.1 Middle East & Africa Iopromide Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Iopromide Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Iopromide Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Iopromide Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iopromide Injection
10.3 Manufacturing Process Analysis of Iopromide Injection
10.4 Industry Chain Structure of Iopromide Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Iopromide Injection Distributors
11.3 Iopromide Injection Customer

12 WORLD FORECAST REVIEW FOR IOPROMIDE INJECTION BY GEOGRAPHIC REGION

12.1 Global Iopromide Injection Market Size Forecast by Region
  12.1.1 Global Iopromide Injection Forecast by Region (2027-2032)
  12.1.2 Global Iopromide Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Iopromide Injection Forecast by Type (2027-2032)
12.7 Global Iopromide Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Bayer HealthCare
  13.1.1 Bayer HealthCare Company Information
  13.1.2 Bayer HealthCare Iopromide Injection Product Portfolios and Specifications
  13.1.3 Bayer HealthCare Iopromide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Bayer HealthCare Main Business Overview
  13.1.5 Bayer HealthCare Latest Developments
13.2 Brilliant Pharmaceutical
  13.2.1 Brilliant Pharmaceutical Company Information
  13.2.2 Brilliant Pharmaceutical Iopromide Injection Product Portfolios and Specifications
  13.2.3 Brilliant Pharmaceutical Iopromide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Brilliant Pharmaceutical Main Business Overview
  13.2.5 Brilliant Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Iopromide Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Iopromide Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 150 mg I/mL
Table 4. Major Players of 240 mg I/mL
Table 5. Major Players of 300 mg I/mL
Table 6. Major Players of 370 mg I/mL
Table 7. Global Iopromide Injection Sales by Type (2021-2026) & (K Units)
Table 8. Global Iopromide Injection Sales Market Share by Type (2021-2026)
Table 9. Global Iopromide Injection Revenue by Type (2021-2026) & ($ million)
Table 10. Global Iopromide Injection Revenue Market Share by Type (2021-2026)
Table 11. Global Iopromide Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Iopromide Injection Sale by Application (2021-2026) & (K Units)
Table 13. Global Iopromide Injection Sale Market Share by Application (2021-2026)
Table 14. Global Iopromide Injection Revenue by Application (2021-2026) & ($ million)
Table 15. Global Iopromide Injection Revenue Market Share by Application (2021-2026)
Table 16. Global Iopromide Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Iopromide Injection Sales by Company (2021-2026) & (K Units)
Table 18. Global Iopromide Injection Sales Market Share by Company (2021-2026)
Table 19. Global Iopromide Injection Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Iopromide Injection Revenue Market Share by Company (2021-2026)
Table 21. Global Iopromide Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Iopromide Injection Producing Area Distribution and Sales Area
Table 23. Players Iopromide Injection Products Offered
Table 24. Iopromide Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Iopromide Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Iopromide Injection Sales Market Share Geographic Region (2021-2026)
Table 29. Global Iopromide Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Iopromide Injection Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Iopromide Injection Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Iopromide Injection Sales Market Share by Country/Region (2021-2026)
Table 33. Global Iopromide Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Iopromide Injection Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Iopromide Injection Sales by Country (2021-2026) & (K Units)
Table 36. Americas Iopromide Injection Sales Market Share by Country (2021-2026)
Table 37. Americas Iopromide Injection Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Iopromide Injection Sales by Type (2021-2026) & (K Units)
Table 39. Americas Iopromide Injection Sales by Application (2021-2026) & (K Units)
Table 40. APAC Iopromide Injection Sales by Region (2021-2026) & (K Units)
Table 41. APAC Iopromide Injection Sales Market Share by Region (2021-2026)
Table 42. APAC Iopromide Injection Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Iopromide Injection Sales by Type (2021-2026) & (K Units)
Table 44. APAC Iopromide Injection Sales by Application (2021-2026) & (K Units)
Table 45. Europe Iopromide Injection Sales by Country (2021-2026) & (K Units)
Table 46. Europe Iopromide Injection Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Iopromide Injection Sales by Type (2021-2026) & (K Units)
Table 48. Europe Iopromide Injection Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Iopromide Injection Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Iopromide Injection Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Iopromide Injection Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Iopromide Injection Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Iopromide Injection
Table 54. Key Market Challenges & Risks of Iopromide Injection
Table 55. Key Industry Trends of Iopromide Injection
Table 56. Iopromide Injection Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Iopromide Injection Distributors List
Table 59. Iopromide Injection Customer List
Table 60. Global Iopromide Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Iopromide Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Iopromide Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Iopromide Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Iopromide Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Iopromide Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Iopromide Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Iopromide Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Iopromide Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Iopromide Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Iopromide Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Iopromide Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Iopromide Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Iopromide Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Bayer HealthCare Basic Information, Iopromide Injection Manufacturing Base, Sales Area and Its Competitors
Table 75. Bayer HealthCare Iopromide Injection Product Portfolios and Specifications
Table 76. Bayer HealthCare Iopromide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Bayer HealthCare Main Business
Table 78. Bayer HealthCare Latest Developments
Table 79. Brilliant Pharmaceutical Basic Information, Iopromide Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. Brilliant Pharmaceutical Iopromide Injection Product Portfolios and Specifications
Table 81. Brilliant Pharmaceutical Iopromide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Brilliant Pharmaceutical Main Business
Table 83. Brilliant Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Iopromide Injection
Figure 2. Iopromide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Iopromide Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Iopromide Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Iopromide Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Iopromide Injection Sales Market Share by Country/Region (2025)
Figure 10. Iopromide Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 150 mg I/mL
Figure 12. Product Picture of 240 mg I/mL
Figure 13. Product Picture of 300 mg I/mL
Figure 14. Product Picture of 370 mg I/mL
Figure 15. Global Iopromide Injection Sales Market Share by Type in 2026
Figure 16. Global Iopromide Injection Revenue Market Share by Type (2021-2026)
Figure 17. Iopromide Injection Consumed in CT
Figure 18. Global Iopromide Injection Market: CT (2021-2026) & (K Units)
Figure 19. Iopromide Injection Consumed in Digital Subtraction Angiography
Figure 20. Global Iopromide Injection Market: Digital Subtraction Angiography (2021-2026) & (K Units)
Figure 21. Iopromide Injection Consumed in Other
Figure 22. Global Iopromide Injection Market: Other (2021-2026) & (K Units)
Figure 23. Global Iopromide Injection Sale Market Share by Application (2025)
Figure 24. Global Iopromide Injection Revenue Market Share by Application in 2026
Figure 25. Iopromide Injection Sales by Company in 2026 (K Units)
Figure 26. Global Iopromide Injection Sales Market Share by Company in 2026
Figure 27. Iopromide Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Iopromide Injection Revenue Market Share by Company in 2026
Figure 29. Global Iopromide Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Iopromide Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Iopromide Injection Sales 2021-2026 (K Units)
Figure 32. Americas Iopromide Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Iopromide Injection Sales 2021-2026 (K Units)
Figure 34. APAC Iopromide Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Iopromide Injection Sales 2021-2026 (K Units)
Figure 36. Europe Iopromide Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Iopromide Injection Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Iopromide Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Iopromide Injection Sales Market Share by Country in 2026
Figure 40. Americas Iopromide Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Iopromide Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Iopromide Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Iopromide Injection Sales Market Share by Region in 2026
Figure 48. APAC Iopromide Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Iopromide Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Iopromide Injection Sales Market Share by Application (2021-2026)
Figure 51. China Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Iopromide Injection Sales Market Share by Country in 2026
Figure 59. Europe Iopromide Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Iopromide Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Iopromide Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Iopromide Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Iopromide Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Iopromide Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Iopromide Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Iopromide Injection in 2026
Figure 76. Manufacturing Process Analysis of Iopromide Injection
Figure 77. Industry Chain Structure of Iopromide Injection
Figure 78. Channels of Distribution
Figure 79. Global Iopromide Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Iopromide Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Iopromide Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Iopromide Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Iopromide Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Iopromide Injection Revenue Market Share Forecast by Application (2027-2032)